Cover Image
市場調查報告書

膽汁滯留:全球臨床實驗檢討

Cholestasis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 235377
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
Back to Top
膽汁滯留:全球臨床實驗檢討 Cholestasis Global Clinical Trials Review, H2, 2016
出版日期: 2016年10月31日 內容資訊: 英文 88 Pages
簡介

本報告提供膽汁滯留相關的臨床研究之最新趨勢分析,提供您疾病·治療方法概要,及G7及E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 膽汁滯留
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美

G7各國的臨床實驗數量: 膽汁滯留臨床實驗數量上消化管疾病臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 膽汁滯留臨床實驗數量上消化管疾病臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 膽汁滯留治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Shire Plc
    • Abbott Laboratories
    • Zhejiang Hisun Pharmaceutical Co., Ltd.
    • AlbireoPharma
    • GlaxoSmithKline plc
    • Celgene Corporation
    • Asklepion Pharmaceuticals, LLC
  • 有代表性的研究機關/醫院臨床實驗概要
    • University of Pittsburgh
    • Boston Children's Hospital
    • National Center for Research Resources
    • University of California, Los Angeles
    • University of Michigan
    • Academic Medical Center
    • Assistance Publique - Hopitaux de Paris
    • Baylor College of Medicine
    • Calicut Medical College
    • Carle Foundation Hospital

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3901CTIDB

GlobalData's clinical trial report, "Cholestasis Global Clinical Trials Review, H2, 2016" provides an overview of Cholestasis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholestasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Cholestasis Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 85

  • Abbreviations 85
  • Definitions 85
  • Research Methodology 86
  • Secondary Research 86
  • About GlobalData 87
  • Contact Us 87
  • Disclaimer 87
  • Source 88

List of Tables

List of Tables

  • Cholestasis Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
  • Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10
  • Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
  • Cholestasis Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
  • Cholestasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
  • Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
  • Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
  • Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Cholestasis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Cholestasis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 10
  • Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
  • Cholestasis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
  • Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14
  • Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17
  • Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Cholestasis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 86
Back to Top